“NEOADJUVANT FOR PATIENTS WITH HIGH AND VERY HIGH RISK PROSTATE CANCER”. Voprosy onkologii 65, no. 5 (May 1, 2019): 726–735. Accessed October 14, 2026. https://voprosyonkologii.ru/index.php/journal/article/view/1021.